##common.pageHeaderLogo.altText##

Original article

Vol. 151 No. 3536 (2021)

Bilateral proximal hamstring muscle avulsion after treatment with immune checkpoint inhibitors and corticosteroids

  • Nicolas Frei
  • Federico Caobelli
  • Diego Kyburz
Cite this as:
Swiss Med Wkly. 2021;151:w30011
Published
08.09.2021

Summary

A 66-year-old man presented with 4 weeks of bilateral buttock pain without previous trauma or intense exercise. He had been treated with immune checkpoint inhibitors because of metastasising melanoma and experienced immune-related adverse events requiring treatment with corticosteroids. Magnetic resonance imaging of the pelvis revealed bilateral avulsion of the proximal hamstring muscles. Treatment with physical therapy and nonsteroidal anti-inflammatory drugs led to a slow but lasting relief. This is, to our knowledge, the first report of symptomatic non-traumatic bilateral hamstring muscle avulsion following treatment with immune checkpoint inhibitors and corticosteroids.

References

  1. Cohen S, Bradley J. Acute proximal hamstring rupture. J Am Acad Orthop Surg. 2007 Jun;15(6):350–5. https://doi.org/10.5435/00124635-200706000-00004
  2. Startzman AN, Fowler O, Carreira D. Proximal Hamstring Tendinosis and Partial Ruptures. Orthopedics. 2017 Jul;40(4):e574–82. https://doi.org/10.3928/01477447-20170208-05
  3. Kwong Y, Patel J, Ramanathan EB. Spontaneous complete hamstring avulsion causing posterior thigh compartment syndrome. Br J Sports Med. 2006 Aug;40(8):723–4. https://doi.org/10.1136/bjsm.2005.022749
  4. Persson R, Jick S. Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids. Br J Clin Pharmacol. 2019 May;85(5):949–59. https://doi.org/10.1111/bcp.13879
  5. Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study. Clin Drug Investig. 2019 Feb;39(2):205–13. https://doi.org/10.1007/s40261-018-0729-y
  6. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003 Jun;36(11):1404–10. https://doi.org/10.1086/375078
  7. Stephenson AL, Wu W, Cortes D, Rochon PA. Tendon Injury and Fluoroquinolone Use: A Systematic Review. Drug Saf. 2013 Sep;36(9):709–21. https://doi.org/10.1007/s40264-013-0089-8
  8. Cappelli LC, Gutierrez AK, Bingham CO 3rd, Shah AA. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature. Arthritis Care Res (Hoboken). 2017 Nov;69(11):1751–63. https://doi.org/10.1002/acr.23177
  9. Inamo J, Kaneko Y, Takeuchi T. Inflammatory tenosynovitis and enthesitis induced by immune checkpoint inhibitor treatment. Clin Rheumatol. 2018 Apr;37(4):1107–10. https://doi.org/10.1007/s10067-018-4035-0
  10. Roberts J, Ennis D, Hudson M, Ye C, Saltman A, Himmel M, et al. Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort. Autoimmun Rev. 2020 Aug;19(8):102595. https://doi.org/10.1016/j.autrev.2020.102595
  11. Daoussis D, Kraniotis P, Filippopoulou A, Argiriadi R, Theodoraki S, Makatsoris T, et al. An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding. Rheumatology (Oxford). 2020 May;59(5):1041–50. https://doi.org/10.1093/rheumatology/kez361
  12. Thompson SM, Fung S, Wood DG. The prevalence of proximal hamstring pathology on MRI in the asymptomatic population. Knee Surg Sports Traumatol Arthrosc. 2017 Jan;25(1):108–11. https://doi.org/10.1007/s00167-016-4253-4